Brief: Pixium Vision: Implantation Of First Patient In Italy In Prima System European Pivotal Trial Primavera
Sept 13 (Reuters) - Pixium Vision SA ALPIX.PA :
* PIXIUM VISION ANNOUNCES IMPLANTATION OF FIRST PATIENT IN
ITALY
IN PRIMA SYSTEM EUROPEAN PIVOTAL TRIAL PRIMAVERA
* PRIMAVERA ON TRACK TO READ-OUT AROUND END OF 2023
* FOLLOWS SUCCESSFUL IMPLANTATIONS AT CLINICAL SITES IN
FRANCE,
GERMANY, UK AND NETHERLANDS
* PRIMAVERA ON TRACK TO READ-OUT AROUND END OF 2023
* STUDY WILL INCLUDE THREE YEARS OF FOLLOW-UP, WITH AN
ASSESSMENT
OF PRIMARY ENDPOINTS AT 12 MONTHS AFTER IMPLANTATION
Source text for Eikon: ID:nGNEc1vdPt
Further company coverage: ALPIX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Pixium Vision SA
See all newsBrief: Pixium Vision SA Says Paris Commercial Court Postponed Decision On Takeover Offer Filed On Nov 20, 2023
Brief: Pixium Vision: opening of judicial liquidation proceedings has been postponed to later date
Brief: Pixium Vision Announces Decision About Adoption Of Sale Plan, Opening Of Judicial Liquidation Proceedings Planned For Jan 16, 2024
Brief: Pixium Vision SA Announces Conversion Of Safeguard Proceedings Into Receivership
Brief: Pixium Vision Announces Tender Process For Purpose Of Finding Buyers To Acquire Company's Business Will Be Published Tomorrow